As the domestic stock market continues its rebound trend, upper limit stocks are surging one after another, drawing investors' attention. With low-price buying inflows following the previous day's sharp decline and strong supply and demand concentrating on some theme stocks, the market atmosphere is reviving.

In the morning stock market on the 11th, Hwashin Precision, Komiko, and Maniker, along with BeautySkin, STX Greenlogis, and CSA Cosmic, rose to their daily price limits, hitting the upper limit. The market prices of major upper limit stocks are as follows.

• Hwashin Precision: 5,750 won (up 29.80%). Trading volume exceeded 11.45 million shares, with strong buying concentrated during the session. • Komiko: 139,200 won (surged 29.97%). It added strength to the strong trend in the semiconductor sector. • Maniker: Settled at the upper limit, rising to 1,340 won (up 29.97%). • BeautySkin: Showed a strong performance, rising to 2,435 won (up 29.94%). • STX Greenlogis: Filled its daily price limit, rising to 3,380 won (up 30.00%). • CSA Cosmic: Surged to 304 won (up 29.91%).

In the market, analyses suggest that expectations of a possible easing of recent military tensions surrounding the US and Iran are acting as a factor in improving investor sentiment. US President Donald Trump held direct conversations with the Iranian side and mentioned the possibility of halting airstrikes, which has partially eased the risk-aversion sentiment in the global financial market.

Experts advised that while the increasing number of upper limit stocks can be interpreted as a sign of recovering market liquidity, for stocks that have surged in the short term, it is necessary to also review their performance and corporate value due to high volatility.

Meanwhile, investors are keeping an eye on future changes in foreign investor trading, US stock market trends, and the development of the Middle East situation to assess the possibility of an additional market rebound.

[This article was written with the assistance of AI. This article is intended to provide information for reference in making investment decisions and does not recommend buying or selling specific stocks. Losses from stock investments are borne by the investor, and investment decisions must be made with sufficient review and under one's own responsibility.]